Cinclus Pharma Holding AB (OSTO:CINPHA) ROE % Adjusted to Book Value : -20.88% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB ROE % Adjusted to Book Value?

Cinclus Pharma Holding AB's ROE % for the quarter that ended in Dec. 2024 was -37.37%. Cinclus Pharma Holding AB's PB Ratio for the quarter that ended in Dec. 2024 was 1.79. Cinclus Pharma Holding AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -20.88%.

Cinclus Pharma Holding AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Cinclus Pharma Holding AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB ROE % Adjusted to Book Value Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

-39.23

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					-	-	-27.33	-10.93	-20.88

Competitive Comparison of Cinclus Pharma Holding AB's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cinclus Pharma Holding AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cinclus Pharma Holding AB's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cinclus Pharma Holding AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cinclus Pharma Holding AB's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Cinclus Pharma Holding AB ROE % Adjusted to Book Value Calculation

Cinclus Pharma Holding AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-70.23%	/	1.79
	=	-39.23%

Cinclus Pharma Holding AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-37.37%	/	1.79
	=	-20.88%

Cinclus Pharma Holding AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines